{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:40:35Z","timestamp":1790314835016,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijantimicag.2020.106215","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T20:54:57Z","timestamp":1603745697000},"page":"106215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["In vitro activity of eravacycline and mechanisms of resistance in enterococci"],"prefix":"10.1016","volume":"56","author":[{"given":"Sarrah","family":"Boukthir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Dejoies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Zouari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Potrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-9912","authenticated-orcid":false,"given":"Vincent","family":"Cattoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106215_bib0001","series-title":"Enterococci: from commensals to leading causes of drug resistant infection","article-title":"Enterococcal infection\u2014treatment and antibiotic resistance","author":"Kristich","year":"2014"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14787210.2014.870886","article-title":"Antibiotic resistance in Enterococcus faecium clinical isolates","volume":"12","author":"Cattoir","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0003","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0004","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00018-009-0172-6","article-title":"The tetracycline resistome","volume":"67","author":"Thaker","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.04174-14","article-title":"Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium","volume":"59","author":"Cattoir","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","article-title":"Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature","volume":"40","author":"Bender","year":"2018","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.meegid.2018.10.018","article-title":"Molecular basis for the emergence of a new hospital endemic tigecycline-resistant Enterococcus faecalis ST103 lineage","volume":"67","author":"Gebieluca Dabul","year":"2019","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0009","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/mdr.2019.0346","article-title":"A nosocomial cluster of tigecycline- and vancomycin-resistant Enterococcus faecium isolates and the impact of rpsJ and tet(M) mutations on tigecycline resistance","volume":"26","author":"Bender","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0010","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.06187-11","article-title":"Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic","volume":"56","author":"Grossman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0011","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/jm201467r","article-title":"Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy","volume":"55","author":"Clark","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0012","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1021\/jm201465w","article-title":"Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent","volume":"55","author":"Xiao","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0013","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/AAC.00366-16","article-title":"Antibacterial efficacy of eravacycline in vivo against Gram-positive and Gram-negative organisms","volume":"60","author":"Monogue","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.diagmicrobio.2017.12.013","article-title":"In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014\u20132015","volume":"91","author":"Zhanel","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02206-17","article-title":"Evaluation of the in vitro activity of eravacycline against a broad spectrum of recent clinical anaerobic isolates","volume":"62","author":"Snydman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0016","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2217\/fmb-2019-0135","article-title":"Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance","volume":"14","author":"Solomkin","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12866-018-1349-7","article-title":"Eravacycline activity against clinical S. aureus isolates from China: in vitro activity","volume":"18","author":"Zhang","year":"2018","journal-title":"MLST profiles and heteroresistance. BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41426-018-0141-y","article-title":"Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104185","article-title":"Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC","volume":"80","author":"Shi","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0020","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/JB.00259-12","article-title":"Comparative analysis of the first complete Enterococcus faecium genome","volume":"194","author":"Lam","year":"2012","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0021","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.43.11.2720","article-title":"Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin\u2013dalfopristin against Enterococcus faecium","volume":"43","author":"Bozdogan","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI Methods Development and Standardization Working Group of the Subcommittee on Antimicrobial Susceptibility Testing. CLSI Methods Development and Standardization Working Group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0023","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/jac\/dkz097","article-title":"Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006\u201316","volume":"74","author":"Sassi","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01326-19","article-title":"Novel plasmid-mediated tet(X5) gene conferring resistance to tigecycline, eravacycline, and omadacycline in a clinical Acinetobacter baumannii isolate","volume":"64","author":"Wang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijantimicag.2018.01.001","article-title":"Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic\/pharmacodynamic analysis","volume":"51","author":"Thabit","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0026","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkv420","article-title":"Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)","volume":"71","author":"Fiedler","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0027","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1128\/AAC.00547-15","article-title":"The ribosomal S10 protein is a general target for decreased tigecycline susceptibility","volume":"59","author":"Beabout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106215_bib0028","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijantimicag.2015.07.009","article-title":"Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium","volume":"46","author":"Niebel","year":"2015","journal-title":"Int J Antimicrob Agents"}],"updated-by":[{"DOI":"10.1016\/j.ijantimicag.2022.106694","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792030426X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792030426X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:08:26Z","timestamp":1671815306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792030426X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S092485792030426X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106215","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of eravacycline and mechanisms of resistance in enterococci","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106215"}}